US Patent 10301395 Chemically-locked bispecific antibodies
Patent 10301395 was granted and assigned to Sorrento Therapeutics on May, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+79 characters)
Article
Patent abstract
Provided are bispecific antibody compounds having the Formula I:
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Gunnar F. Kaufmann0
James T. Patterson0
Yanwen Fu0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
103013950
Date of Patent
May 28, 2019
0Patent Application Number
153539790
Date Filed
November 17, 2016
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Mar, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 7 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 26 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10301395 Chemically-locked bispecific antibodies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10301395
Date of patent
May 28, 2019
Patent application number
15353979
Date Filed
November 17, 2016
Patent primary examiner
Find more entities like US Patent 10301395 Chemically-locked bispecific antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
